AFEW Builds Models for the Future with Improved TB/HIV Care

AFEW, Hivos and PharmAccess and KNCV representatives after the presentation on the Dutch congress ‘Soa.Hiv.Seks’

The ‘Improved TB/HIV Prevention & Care – Building Models for the Future’ project was presented during the Dutch National Congress ‘Soa.Hiv.Seks’ on 1 December 2017 in Amsterdam, the Netherlands. Three working models from Kazakhstan, the Philippines, and Nigeria implemented by AFEW, Hivos and PharmAccess with KNCV Tuberculosis Foundation as the lead agency were shown to the Congress audience.

HIV and TB are two of the biggest public health threats in the world. Mounting challenges associated with these mutually reinforcing diseases are both medical and socio-political. In the efforts to address many of the common challenges, AFEW, HIVOS, PharmAccess and KNCV, with support from the Dutch Ministry of Foreign Affairs, collaborate in different parts of the world via the ‘Improved TB/HIV prevention and care-building models for the future’ alliance to jointly design and pilot innovative models of cooperation between the public, private and community sectors involved in the fight against HIV and TB, to find new ways of ensuring and expanding affordable, patient-centred and high quality access to care for key affected populations.

“After the project has started in Almaty, Kazakhstan, we can observe positive changes. A patient has information about good quality care, knows where to go for treatment and support, and has a choice in seeking care in the public sector, private sector and civil society,” the executive director of AFEW International Anke van Dam is saying. “Self-support groups and client management for TB patients are being organized and the HIV and TB working group is supported by the head of the Almaty City Health Department.”

Private clinics in Kazakhstan are now engaged in the public healthcare sector. They are integrated into the national monitoring and evaluation system for public/non-public TB/HIV care provision in Almaty city.

AIDS Day in Ukraine: Online Test, Quest for Adolescents

Author: Yana Kazmirenko, Ukraine

On December 1, an online HIV test was presented in Kyiv

On December 1, a wide range of activities marked the World AIDS in Ukraine. On this day, the first in Ukraine online test for HIV was presented in Kyiv. It is available at HIVtest.com.ua or via a mobile application ‘HIV test.’

“The test makes an audit of your health, rapidly assessing the risk of infection, and offers information about the nearest testing sites,” said Dmitry Sherembey, the Chairman of the Coordination Council of the All-Ukrainian Network of PLWH.

Four weeks before the campaign, organizers placed billboards with the intriguing social advertising – a dangerous blade hidden in a juicy burger ­– in the streets of Kyiv. Dmitry Sherembey reveals the intrigue: for many people HIV is invisible, with 130 thousand out of 250 thousand people living with HIV in Ukraine not aware of their diagnosis.

The test contains about two dozen of questions – their number depends on the respondent’s lifestyle. For example, the question “Do you use condoms when having sex or not?” is relevant in Ukraine, where 51% of people living with HIV get infected through the sexual route of transmission. After a person answers all the questions, the test will show the probability of HIV infection and will show the information about the nearest clinic or confidential counseling room to get tested. The online test has been developed for two months and, according to Dmitry Sherembey, it shows the result that person is getting after the testing in 40% of cases.

Testing should become a routine procedure

Dmitry Sherembey shows the online test on his phone

According to Pavel Skala, Director of the Policy and Partnership at the Alliance for Public Health, the annual campaigns dedicated to the World AIDS Day should be changing and moving forward. On one hand, public awareness on HIV is growing, but on the other hand – people are losing interest in the repeating topics.

Testing should become a routine procedure for every Ukrainian, emphasizes Roman Ilyk, the Deputy Minister of Health. He says that over 50% of cases are diagnosed at the third and fourth clinical stages of HIV infection, when the person’s health is poor. 80% of people who die are 25-49 years old. The Ministry of Health called on Ukrainians to get tested for HIV and underlined that early detection of the disease allows to timely access treatment.

Interactive activities for teenagers

Every year, civil society organizations conduct campaigns for teenagers dedicated to the World AIDS Day. Alexander Mogilka, the coordinator of the social support project for adolescents at the Kharkiv Day Care Center for Children and Youth “Compass” thinks that the success of Ukraine in curbing the HIV epidemic largely depends on the progress in working with this target group. This year, “Compass” organized a quest called “The Safety Route” in Chervonohrad, Kharkiv region.

Teenagers from Chervonohrad walked the Safety Route

“The format of this game was developed by the German agency GIZ. The teams are to go through several checkpoints: contraception, routes of HIV transmission, environment assessment. When you answer a question, you may go to the next point,” tells Alexander.

He claims that 70% of “troubled” teenagers have experience of using drugs. Usually, these are children from dysfunctional families.

“Before, teenagers could access drugs through dens, but now they can just use internet and stashes hidden in agreed venues. There is a sad contrast: the drug business is developing and taking new forms and the prevention is lagging behind,” sums up Alexander.

He underlines that to develop new formats of working with young people – combining quests, flash mobs, and social campaigns – is a new challenge for civil society organizations.

The Train is off but HIV Stays

Author: Anastasia Petrova, Russia

Testing in Kurgan

From 8 July to 20 October 2017, a train carriage went throughout the territory of Russia offering HIV testing services to everyone interested. The campaign was aimed at raising the awareness and increasing the coverage with testing services among the general public.

The strategic train

The train offering HIV testing is a project of the Russian Ministry of Health in cooperation with the Russian Railways. The campaign was initiated within the State Strategy to Combat the Spread of HIV in Russia through 2020. Long-distance passenger trains were equipped with an additional carriage offering free and confidential testing. Project workers conducted pre- and post-test counseling and informed people about HIV and the ways of its transmission. The route lied from Vladivostok to St. Petersburg and included the regions most affected with HIV. Apart from offering HIV testing on the way, mobile laboratories were also functioning on the railway stations. The campaign was aimed at the first component of the global 90/90/90 strategy, which stipulates that 90% of people living with HIV should be aware of their status.

The silent epidemic

The carriage where the testing was conducted

The testing campaign covered 24 regions, with the following cities leading in terms of people tested: Chelyabinsk (2,039 people), Nizhnevartovsk (1,645 people), Irkutsk (1,446 people), Kurgan (1,290 people), and Samara (1,227 people). Moscow was the city with the lowest coverage – only 290 people got tested there. According to the Ministry of Health, within the campaign 25 thousand people were able to get tested and receive professional counseling in the carriage and in railway stations.

“The fact that those 24 regions were covered is important. Here in Russia, 10 out of 85 regions have 50% of new HIV cases, and as for the 24 regions covered, they have over 70% of such cases. That is why I think that this campaign has a concrete result as it is focused on the most affected regions,” the chief independent expert in HIV diagnostics and treatment at the Russian Ministry of Health, Yevgeny Voronin is saying.

Awareness-raising materials in the format of railway tickets

It is interesting that no official statistics was announced on the total number of HIV cases detected. However, according to the Minister of Health, Veronika Skvortsova, as of the date when the train was passing Moscow the number of HIV positive cases detected was 248. Thus, the total number of such cases is more than 250 or 1% of the people tested. Considering the fact that testing was conducted in the general population, this number shows the severe epidemiological situation in the country and proves the tendency of HIV epidemic going beyond the key populations.

The train is off

Such campaign is an unprecedented intervention aimed at raising the awareness of people in the area of HIV/AIDS. Apart from testing passengers, the campaign was an important newsmaker. Reports in federal and regional mass media allowed millions of people in Russia to learn about the importance of this problem and about the necessity of regular testing. A positive outcome is that after the train left mobile sites to continue testing remained at some railway stations.

Closing ceremony in St. Petersburg

Alongside with that, if the data about one percent of the HIV cases detected in the general population is confirmed, it will mean that the situation has got out of control. In this case, the measures taken by the Ministry of Health are to be scaled up a hundred times and are to be aimed not only at awareness raising and detection of new cases but also at treatment. Testing as it is is not a measure of response to the epidemic. Every patient should receive therapy in order to achieve minimal viral load not to transmit the virus to other people. However, in Russia less than a half of people living with HIV get the necessary medications.

 

“I have HIV and it is not a verdict”

Amina from Tajikistan lives with HIV for nine years

Author: Nargis Hamrabaeva, Tajikistan

In her memories, her life is divided into ‘before’ and ‘after’ she learned she had HIV. As strange as it may seem, with the therapy ‘after’ is not a verdict, not a tragedy, not the end…

We are meeting 29-year-old Amina (the name has been changed) in one of the coffee houses in Dushanbe, Tajikistan. She came to our meeting after work, short of breath, as she was afraid to be late. Good looking, with a glow of health on her cheeks, a strand of hair appearing from under her neatly tied headscarf, and snow-white teeth. One could say that she was to the full of her health.

Sipping her coffee, she tells her story. Amina has been living with HIV for nine years and she is not at all ashamed of her status. She is convinced that a person with such diagnosis may live the same life as with any other chronic disease. The main thing is to take antiretroviral (ART) therapy on time and attend medical check-ups.

Fire, hospital, blood transfusions…

In 2007, Amina married her distant family member. In fact, as it often happens in Tajik families, her parents arranged their marriage.

“It happened that my two sisters married the relatives of my father and to keep some kind of “balance,” my marriage was arranged with my mother’s family relative. I struggled. We lived in the house of my husband’s parents. My sisters-in-law, who moved back to their parents’ house after the divorce, also lived with us. I could only dream of a quiet life,” tells Amina.

Sometimes, the young woman became an object of her sisters-in-law’s vengeance after their quarrels with her husband. Once, after another big quarrel, Amina made a bonfire in the yard and was cooking some food in a big pot. She already had a one-year-old and was pregnant with her second baby. The girl was throwing more brushwood into the fire to make it stronger when suddenly someone approached her from behind and pushed her right into the flame…

Amina woke up in a hospital ward several days after. She was in awful pain – she had 40% of her skin burnt. Ahead, she had two months of hospital stay, treatment, loss of her baby, interrogations of police officers and many blood transfusions. It turned out that it was one of her sisters-in-law who pushed her into the fire.

After several months, the wounds of her body and soul were healed and Amina got pregnant again. As all pregnant women, she did all the required tests, including an HIV test. It came back positive. She was worried, desperate, scared. She did not know what to do. Professional psychologists of the AIDS center talked to her and explained that it was not the end, that she would need to take her therapy and would be able to live a normal life with certain conditions.

“You have HIV and you will die in half a year”

However, the conversation with her husband was hard.

“He also got tested and his result was negative. He blamed it all on me; said that if I have HIV, I would die in half a year. He said that he wanted neither me nor our child. Soon I gave birth to our second son, but it did not save our marriage. We broke up. Both my boys are HIV-negative,” adds Amina.

She thinks that she got infected during one of the blood transfusions in the hospital.

“After the diagnosis, you can and should go on living your life,” the woman is saying now. Earlier, she was alone and hopeless. Her children were her only comfort. For them, she was fighting for her life. “I have been taking ART for five years. It includes several drugs, each of which influences a certain stage in the HIV replication cycle. In other words, when a person takes the therapy, the virus no longer replicates in the cells of his immune system.”

Building a house and finding a true love

A local organisation working with HIV-positive women helped Amina to become stronger and believe in herself. Now the young woman works as an outreach worker there, helping other women who are diagnosed with HIV to overcome their fears and depression. Her two wonderful boys are growing up. One of them goes to the third grade, and the second one has started his first year in school.

“To my ex-husband’s surprise, I am still alive, though nine years have already passed,” she says with a smile on her face. “Money that I make here is enough for us, but I am afraid to think about what can happen if the project is closed. Now there is a crisis everywhere. I could go to Russia to earn some money, but there I would have to make a mandatory HIV test to get a job and then I might face deportation.”

“What is your dream?”, I am asking her.

“Now I am on a waiting list to get a land plot and I would like to build a house for my children,” says Amina. Currently, she lives with her mother and her brother’s family. “They are all well aware of HIV, they know the routes of transmission, so they are not afraid to give me a hug or to eat from one bowl with me, and my brother’s wife sometimes leaves her children for me to look after.”

Besides, Amina is dreaming about meeting her true love and creating a family. This strong and self-confident young woman may be a role model for many people living with HIV.

With Tuberculosis, it is Important to Take Medicine and Believe in Yourself

Sultanmurat from Kazakhstan wanted to get cured of tuberculosis no matter what but the treatment was difficult

Sanat Alemi is one of the civil society organizations (CSOs) supported by the Improved TB/HIV prevention & care – Building models for the future project which gives support to TB patients and their relatives. Founded in 2016 in Almaty, Kazakhstan by a group of ex multidrug-resistant or extensively drug-resistant TB patients, they quickly showed successes through their established self-support groups as well as one-to-one TB patient support. Sanat Alemi is also implementing several community-based activities such as social mobilization, advocacy, and communication to improve TB literacy among people affected by TB, TB/HIV, AIDS and other socially significant diseases (drug abuse, alcoholism, etc), aiming at reducing stigma, discrimination.

Success is possible with trust and professionals

“The social support for TB patients plays a key role in increasing adherence to the treatment. The success in treatment is possible with the combination of trust, human relationships and the support of professionals, such as a psychologist and social worker,” the current director of Sanat Alemi Roza Idrisova is saying.

A TB patient and client of Sanat Alemi Sultanmurat did not know anything about tuberculosis, except that it was a dangerous disease.

“I was horrified when I heard I had TB. I could not even imagine how I got it. I started coughing blood which was so scary, but I did not suspect that it could be TB,” he says. “I thought that the pain was caused by my liver or another internal organ. I told about this to my mother, as she is my closest relative. The other relatives reacted with understanding and this helped me a lot.”

What does not kill us makes us stronger

Sultanmurat wanted to get cured no matter what but the treatment was difficult. In the beginning, he could not tolerate the drugs, and he developed allergies.

“I struggled and tried not to miss a single day of medications and injections. I heard about Sanat Alemi from other patients and started to attend their self-support groups. Receiving support from other patients and social workers during treatment is of great help and being able to join trainings and meetings with different specialists is very useful and gives a lot of interesting information. I had the opportunity to ask questions that I had for a long time. I believe that in the future Sanat Alemi will keep the same spirit and will support many other TB patients,” Sultanmurat says. “TB completely changed my life. I started to appreciate life and learned to tolerate the sickness. I started to appreciate and love my relatives even more as they proved once again that they are there for me and that they would never give up on me during difficult times.”

Sultanmurat would like to say to other TB patients that this disease is curable like many other diseases. The most important thing is to follow the treatment, take pills without interruption, eat well and do sports. It is also important to be friendly, always and everywhere provide support and assistance to other people with TB. The most important thing is to believe in the best, in your recovery and do not forget that what does not kill us makes us stronger.

Undetectable means Untransmittable: Anti-Stigma Campaign in EECA countries

Informational materials of the campaign

AFEW International supports the large-scale campaign “Неопределяемый значит не передающий” (Undetectable means Untransmittable) aimed at overcoming stigma against people living with HIV. Experts and activists from Eastern European and Central Asian countries also take part in the flash mob.

Research studies confirm the effectiveness of the “treatment as prevention” approach to prevent the sexual pathway of the spread of HIV. In 2014, the PARTNER study conducted in 14 European countries, showed no cases of HIV transmission in 44,000 cases of unprotected sex in discordant couples (1,145 couples totally took part in the study). The study report, published in 2016, showed a complete absence of HIV transmission in more than 58,000 cases of condomless sex.  In July 2017, the Opposites Attract study gave additional evidence in favor of the fact that HIV is not transmitted if the viral load is undetectable. This study was conducted in Australia among 358 serodiscordant gay couples in Australia, Thailand, and Brazil, and showed zero cases of HIV transmission among HIV positive people with undetectable viral load and their sexual partners. Just recently, in September 2017, the US Centers for Disease Control and Prevention (CDC) confirmed the thesis that undetectable viral load prevents sexual transmission of HIV. In November, the Lancet HIV wrote that “CDC officially backing the science behind the campaign is another key step towards U=U being the most important message of 2017 in the fight against HIV.”

Michel Kazatchkine, United Nations Secretary-General’s Special Envoy for AIDS in Eastern Europe and Central Asia

“Н = Н” is the Russian-language part of the global U = U (Undetectable means Untransmittable) campaign, which was launched by American activist Bruce Richman in early 2016. Its core is the Consensus Statement of experts and professional organizations that undetectable viral load prevents sexual transmission of HIV. By November 2016, more than 475 organizations from 65 countries of the world joined the campaign. Currently, more AIDS centers, NGOs, and activist organizations from the EECA countries keep joining the campaign. Signatures have been received from Armenia, Belarus, Georgia, Ukraine, Moldova, Kazakhstan, Kyrgyzstan, Russia, and Estonia. In our region, the campaign is supported by Life4me+.

Today, the science provides more and more evidence that undetectable viral load prevents sexual transmission of HIV, but in Eastern Europe and Central Asia a few people except experts are aware of it. The first Russian-language campaign “Н=Н” (Неопределяемый значит не передающий, Undetectable means Untransmittable), aims to convey this information to as many people as possible. For this purpose, the Consensus Statement and information about the campaign have been translated into Russian.

From October 16 to December 1, 2017, the participants of the campaign tell that today there is an opportunity to curb the spread of HIV through broad access to treatment, early detection and high adherence, and that the stigma of people living with HIV is based on groundless fears and outdated views on the epidemic. The key message of the campaign is that HIV is no longer the “plague of the XXI century.”  It is a chronic infection, with which one can have a good quality of life. With HIV, people can create families and have children, run marathons and make great careers, grow old and retire, just like people without HIV.

It is important to remember that “U=U” does not mean the possibility of not using other means of prevention. Unprotected sex can still lead to sexually transmitted diseases and unwanted pregnancies. In addition, due to limited access to treatment or other reasons, people may have obstacles to achieving an undetectable viral load.

Everyone from any Eastern Europe and Central Asia country can join the campaign. Organizations can sign the Consensus Statement, and individuals are invited to participate in an online flash mob by making a photo with the campaign logo and uploading it on social networks with a hashtag “НравноН.”

 

AIDS 2018: Abstract Submission Guidelines

Scientific tracks

The 22nd International AIDS Conference (AIDS 2018) welcomes submission of abstracts for original contribution to the field in the following scientific tracks:

  • Track A: Basic and translational research
  • Track B: Clinical research
  • Track C: Epidemiology and prevention research
  • Track D: Social and political research, law, policy and human rights
  • Track E: Implementation research, economics, systems and synergies with other health and development sectors

Each scientific track is divided into a number of track categories. All abstract authors are asked to choose one scientific track and one track category during the submission process.

By submitting an abstract to the conference, you agree to adhere to the conference embargo policy. The policy specifies that while authors may publish the fact that their abstract has been selected for inclusion in the conference programme, data from the abstract may NOT be shared in any form (print, broadcast, or online publication, media release or conference presentation) prior to its official presentation at AIDS 2018.

Call for abstracts

We encourage work that introduces new ideas, concepts, research and deepens understanding in the field, as well as analyses of both successes and failures. Please read the following guidelines carefully before submitting your abstract:

  • Abstracts can only be submitted online via the conference profile on our website aids2018.org; submissions by fax, post or email will not be considered.
  • All abstracts must be written in English.
  • It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact in the abstract text will be reproduced as typed by the author. Abstract titles will be subject to a spell check if the abstract is selected for presentation.

Late breaker abstracts

A small number of late breaker abstracts will be accepted for oral or poster presentation at the conference. Late breaker submissions must be data of unquestioned significance that meet a high threshold of scientific merit.

During submission, authors will have to justify why their abstract should be considered as a late breaker. The same submission rules apply for the late breaker abstracts as for the regular abstracts, but each presenting author may only present one late breaker abstract at the conference. The late breaker abstract submission will be open from 19 April to 10 May 2018.

The percentage of abstracts selected for late breakers will depend on the number of submissions, but selection will be far more rigorous than for regular abstracts.

Questions

  • For technical questions regarding the abstract submission system, please contact the abstract support team at abstracts@aids2018.org.
  • Questions regarding the content of the abstract should be addressed to the Abstract Mentor Programme at mentor@aids2018.org.

Policies for abstract submission

Copyright policy

Abstracts should not include libelous or defamatory content. Material presented in abstracts should not violate any copyright laws. If figures/graphics/images have been taken from sources not copyrighted by the author, it is the author’s sole responsibility to secure the rights from the copyright holder in writing to reproduce those figures/graphics/images for both worldwide print and web publication. All reproduction costs charged by the copyright holder must be borne by the author.

Resubmission policy

An abstract which has been previously published or presented at a national, regional or international meeting can only be submitted provided that there are new methods, findings, updated information or other valid reasons for submitting.

The 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), at the Vancouver Convention Centre in Vancouver, British Columbia, Canada.
Photo ©Steve Forrest/Workers’ Photos/IAS

If preliminary or partial data have been published or presented previously, the submitting author will be required to provide details of the publication or presentation, along with a justification of why the abstract merits consideration for AIDS 2018. This information will be considered by the Scientific Programme Committee when making final decisions.

If the author neglects to provide these required details and justification, or if evidence of previous publication or presentation is found, the abstract will be rejected.

Plagiarism

The conference organizers regard plagiarism as serious professional misconduct. All abstracts are screened for plagiarism and when identified, the abstract and any other abstracts submitted by the same author are rejected. In addition, the submitting author’s profile and scholarship application, in the case one has been submitted, will also be canceled.

Co-submission

AIDS 2018 may negotiate co-submission of abstracts with affiliated events, pre-conferences and/or external events. Visit www.aids2018.org for updated information.

Ethical Research Declaration

The conference supports only research that has been conducted according to the protocol approved by the institutional or local committee on ethics in human investigation. Where no such committee exists, the research should have been conducted in accordance with the principles of the Declaration of Helsinki of World Medical Association. The AIDS 2018 Scientific Programme Committee may enquire further into ethical aspects when evaluating the abstracts.

Conference embargo policy

As is the case with most scientific/medical conferences, abstracts from AIDS 2018 are released to delegates and media under a strict embargo policy. A detailed breakdown of the embargo policies for different types of abstracts is available here. All conference delegates, presenters and media agree to respect this policy.

Abstract submission process

Conference profile

Before submitting an abstract, authors must create a conference profile. More than one abstract can be submitted through the conference profile. After an abstract has been created, modifications can be made until the submission deadline. The final deadline to submit the abstract is 5 February 2018, 23:59 Central European Time.

Choosing a track category

The track category is the general heading under which the abstract will be reviewed and later published in the conference printed matters if accepted. The track category which best describes the subject of the abstract should be chosen. During the submission process, you will be asked to select one track category for your abstract.

Abstract structure

The conference offers two options for abstract submission:

Option 1

Suited for research conducted in all disciplines. Abstracts submitted under the first option should contain concise statements of:

  • Background: indicate the purpose and objective of the research, the hypothesis that was tested or a description of the problem being analysed or evaluated.
  • Methods: describe the study period/setting/location, study design, study population, data collection and methods of analysis used.
  • Results: present as clearly and in as much detail as possible the findings/outcomes of the study. Please summarize any specific results.
  • Conclusions: explain the significance of your findings/outcomes of the study for HIV prevention, treatment, care and/or support, and future implications of the results.

The following review criteria will be used in scoring abstracts submitted under option 1:

  • Is there a clear background and justified objective?
  • Is the methodology/study design appropriate for the objectives?
  • Are the results important and clearly presented?
  • Are the conclusions supported by the results?
  • Is the study original, and does it contribute to the field?

Option 2

Suited for lessons learned through programme, project or policy implementation or management. Abstracts submitted under the second option should contain concise statements of:

  • Background: summarize the purpose, scope and objectives, of the programme, project or policy;
  • Description: describe the programme, project or policy period/setting/location, the structure, key population (if applicable), activities and interventions undertaken in support of the programme, project or policy;
  • Lessons learned: present as clearly and in as much detail as possible the findings/outcomes of the programme, project or policy; include an analysis or evaluation of lessons learned and best practices. Please summarize any specific results that support your lessons learned and best practices;
  • Conclusions/Next steps: explain the significance of your findings/outcomes of the programme, project or policy for HIV prevention, treatment, care and/ r support, and future implications of the results.

The following review criteria will apply to abstracts submitted under option 2:

  • Is there a clear background and justified objective?
  • Is the programme, project or policy design and implementation appropriate for the objectives?
  • Are the lessons learned or best practices important, supported by the findings and clearly presented?
  • Are the conclusions/next steps supported by the results and are they feasible?
  • Is the work reported original, and does it contribute to the field?

Disaggregated sex and other demographic data in abstracts

Authors are encouraged to provide a breakdown of data by sex and other demographics such as age, geographic region, race/ethnicity, and/or other relevant demographic characteristics in submitted abstracts, when appropriate. Your abstract should include the number and percentage of men and women (and additional breakdown by gender and/or ethnicity if appropriate) that participated in your research or project, and results should be disaggregated by sex/gender and other relevant demographics. Analyses of any gender-based differences or any other differences between sub-populations should be provided in the Results or Lessons Learned sections, if relevant.

Font

A standard font, e.g. Arial, should be used when formatting the text. This helps to prevent special characters from getting lost when copying the text to the online abstract submission form. Ensure to check the final abstract with the system’s preview function before submission, and edit or replace as necessary.

Word limits

The abstract text body is limited to 350 words. Titles are limited to 30 words.

A maximum of one table and one graph/image can be included: a graph/image (in JPG, GIF or PNG with ideally 600 dpi) can be included. These will not count toward the word limit, nor will the information about authors, institutions and study groups.

Common reasons for abstract rejection:

  • Abstract poorly written.
  • Not enough new information.
  • Clear objective and/or hypothesis missing.
  • Linkage between different parts of the abstract not comprehensible.
  • Duplicate or overlap with another abstract.
  • Study/project/programme/policy too preliminary or insufficient to draw conclusions.
  • Study/project/programme/policy lack of originality.

Reasons for abstract rejection – specific to Option 1:

  • Methods (either quantitative or qualitative) inadequate and/or insufficient to support conclusions;
  • Summary of essential results inadequate and/or missing.

Reasons for abstract rejection – specific to Option 2:

  • Description inadequate and/or insufficient to support conclusions;
  • Lessons learned inadequate and/or missing.

Recommendations

  • Abstracts should disclose primary findings and avoid, whenever possible, promissory statements such as “experiments are in progress” or “results/lessons learned will be discussed”;
  • If English is not your native language, we recommend that you have your abstract reviewed by a native speaker before submission;
  • The conference offers an Abstract Mentor Programme for less experienced submitters. Please see further information below.

Submission confirmation

After submission of the abstract, a confirmation email will be sent to the abstract submitter. In order to receive confirmation, please ensure that emails from abstracts@aids2018-abstracts.org are not marked as spam by your e-mail provider.

Support programmes

Abstract Mentor Programme

The goal of the AIDS 2018 Abstract Mentor Programme is to provide an opportunity for young and/or less experienced abstract submitters to have their draft abstracts mentored by more experienced authors before submitting their abstract to the conference.

Abstracts submitted by authors that have volunteered to be a mentor in the programme will not automatically be accepted. The same applies for abstracts submitted by authors that were mentored by the programme.

For more information please visit Abstract Mentor Programme webpage.

Scholarship application process

Abstract authors interested in applying for a scholarship must complete a full scholarship application, available through your Conference Profile from 1 December 2017 to 1 February 2018.

For more information please visit Scholarship Programme webpage.

Abstract review and selection process

Abstract review

All submitted abstracts will go through a blind peer-review process carried out by an international reviewing committee. Each abstract will be reviewed by at least three reviewers.

Abstract selection

The Scientific Programme Committee makes the final selection of abstracts to be included in the conference programme. Abstracts can be selected for oral presentation in oral abstract sessions or to be presented as a poster. A small number of highest-scoring posters are selected for presentation in oral poster discussion sessions; the majority of the posters will be displayed in the Poster Exhibition.

Notification of acceptance or rejection to the corresponding author

Notification of acceptance or rejection will be sent to the submitting (corresponding) author by mid-April. Please note that only the corresponding author will receive an email concerning the abstract and is responsible for informing all co-authors of the status of the abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract.

Rule of two

Each presenting author may present a maximum of two abstracts at the conference. The number of submissions is, however, not limited. Should an author have more than two abstracts accepted for presentation, a co-author must be named as presenting author for one or more abstracts.

In addition, each presenting author may also present one late breaker abstract at the conference.

Publication of accepted abstracts

The submission of the abstracts constitutes the authors’ consent to publication. If the abstract is accepted, the authors agree that their abstracts are published under the Creative Commons Attribution 3.0 Unported (CC BY 3.0) license. The license allows third parties to share the published work (copy, distribute, transmit) and to adapt it for any purposes, under the condition that AIDS 2018 and authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear. Authors retain the copyright of their abstracts, with first publication rights granted to the IAS.

Accepted abstracts may, therefore, be published on IAS websites and publications, such as the AIDS 2018 Online Conference Programme and other conference materials, the IAS abstract archive, the Journal of the International AIDS Society (JIAS), etc.

Source: AIDS 2018

The Digital Consultation from the Amsterdam Youth Force

Dutch Ambassador for Sexual and Reproductive Health and Rights & HIV/AIDS Lambert Grijns

We are glad to announce the digital consultation the Amsterdam Youth Force (AYF) is organising in the run up to 22nd International AIDS Conference (AIDS 2018.) AIDS 2018 will be an important event in the road to fulfilling the Sustainable Development Goals goal of ending the AIDS epidemic by 2030. Therefore, it is crucial that young people’s perspectives are heard in the lead up to the conference, which is why we a consultation to help produce position papers reflecting young people’s voices is being launched.

The consultation will build on the work the #UPROOT agenda documented by PACT, and Amsterdam Youth Force is currently investigating the best ways to do that. In the meantime, AYF is looking for volunteers to help with the project. They are specifically looking for:

  • Young people who speak both English and Russian, French, Arabic, Spanish or Chinese.
  • People who want to help manage and translate input in those languages and help write the papers.
  • People who are available for that from January until July 2018.

If you are interested in helping out, please let AYF know via advocacy.ayf@gmail.com. Then they will contact you to see how you can help.

People Living with HIV Can Live Longer

Brussels, 29 November 2017 – Experts unveiled a set of recommendations to address health problems facing people living with HIV. Treatments are helping people with HIV live long lives, but they face higher risk than others of serious illnesses – from cancer to heart disease to depression.

As people living with HIV require access to a range of health services beyond just their HIV treatment, a coordinated and personalised approach to long-term HIV care is needed, according to the HIV Outcome recommendations, which were unveiled at an event at the European Parliament.

“There is huge room for improvement” said Nikos Dedes, Chair of the European AIDS Treatment Group (EATG) and Co-Chair of the HIV Outcomes Steering Group. “It is great that people living with HIV can live nearly as long as anyone else these days because of new treatments, but there are complicated health problems that are being ignored. The HIV Outcomes initiative has put together a list of suggestions that has the potential to improve the lives of Europeans who live with HIV.”

In a timely reminder ahead of World AIDS Day on Friday, 1 December, the HIV Outcomes initiative highlights that the advent of modern antiretroviral therapies (ART) has transformed the lives of people living with HIV. For those diagnosed and treated early, it is now a chronic, rather than a fatal, condition. However, this is no guarantee of good health outcomes or quality of life; further effort is needed to develop effective, lifelong approaches to the long-term treatment and care of people living with HIV.

To address these needs, the HIV Outcomes initiative has engaged in a year-long multi-stakeholder process to develop a series of five detailed policy recommendations. These call for an integrated and patient-centred approach to long-term HIV care, which should include services for the prevention, treatment and management of other health conditions (comorbidities), services for mental health conditions, personalised care plans, and advice and support on sexual and reproductive health. Other recommendations call for monitoring of how health systems currently respond to the long-term health challenges faced by people living with HIV as well as efforts to combat stigma and discrimination within health systems.

Recommendations

  1. Adopt an integrated, outcomes-focused, and patient-centred approach to long-term care.

  2. Expand national monitoring of long-term care and outcomes.

  3. Fund studies to provide information on the long-term health of people living with HIV.

  4. Combat stigma and discrimination within health systems.

  5. Upscale involvement of the HIV community in priority setting at country level.

The next step is to ‘road test’ the recommendations at national level in two countries – Italy and Sweden – during 2018. Both have already demonstrated their commitment to people living with HIV; Italy has published a ‘White Book’ on the chronic care model for HIV, while Sweden is the first country to achieve the UNAIDs ‘90-90-90’ targets.The three Member of the European Parliament (MEPs) supporting the event meeting, Christofer Fjellner (European People’s Party, EPP), Eva Kaili (Socialists and Democrats, S&D) and Gesine Meissner (Alliance for Liberals and Democrats in Europe, ALDE), agreed, “Having addressed the issue of longevity, society now needs to help people with HIV to retain good health and lead rewarding lives. As representatives of the European Parliament’s leading political groups, we fully support the aims of this initiative.

The learnings and best practice generated on a national level will ultimately be reported at a future event in the European Parliament in 2018 and should provide further refinements to efforts to improve the long-term health outcomes and quality of life of people living with HIV. It is time to expand our ambitions for the health and well-being of people living with HIV beyond just viral suppression.

Tuberculosis is Finally Getting on the Agenda of the Heads of State

22 November 2017, Geneva, Switzerland – Last week, 75 ministers agreed to take urgent action to end TB by 2030 at the conclusion of the WHO Global Ministerial Conference on ‘Ending TB in the Sustainable Development Era: A Multisectoral Response’ in Moscow, Russia. President Vladimir Putin of the Russian Federation gave the keynote speech on the first day of the Conference on 16 November. The first high-level plenary started with the welcome address of Amina J Mohammed, UN Deputy Secretary. The Conference was opened by Veronika Skvortsova, Minister of Health, Russian Federation, Dr Tedros Adhanom Ghebreyesus, WHO Director-General, Zsuzanna Jakab, WHO Regional Director for Europe, Dr Aaron Motsoaledi, Minister of Health of South Africa and Chair of the Stop TB Partnership, and Timpiyan Leseni, TB survivor from Kenya. The meeting was attended by ministers and country delegations, as well as representatives of civil society and international organizations, scientists, and researchers. More than 1000 participants took part in the two-day conference which resulted in collective commitment to ramp up action to end TB.

“In order to achieve a radical change in the fight against this disease, new approaches are needed, both at the national and international level, as well as the joint work of governmental agencies, public and professional organizations. Only coordinated and consistent actions will help us achieve a final victory over TB. We expect these steps to be supported at the highest level – by the General Assembly of the United Nations, whose meeting next year will focus on the problems of TB,” said the President of Russia Vladimir Putin.

“The UN HLM on TB is the moment we have all been waiting for, and we will we seize the moment. No more calls for action, we need commitment. Together I know we can do it, it will not be easy but we must believe it is possible. This house is full, the attendance of so many ministers shows the commitment but we need to prepare for real commitment,” said Dr Tedros, WHO Director-General.

Speaking at the opening of the Global Ministerial Conference on TB, Minister of Health of South Africa and Chair of Stop TB Partnership, Dr Aaron Motsoaledi emphasized the need to elevate the discussions and engagement to end TB at the level of heads of state and government and UN leaders. “Tuberculosis kills more than 4500 people every day and it is time to be seriously addressed with the support and engagement of the heads of governments. We need to ensure that going towards the UNHLM in New York in September 2018, we have a very strong participation, a very strong Political Declaration and a very strong accountability framework.  If we want this, we need  to have good quality data on TB and for it to be user friendly that heads of state, ministers of finance and even ministers of health can rapidly see the status of their epidemic and targets,” said Dr Motsoaledi.

On this occasion, the Minister launched the Stop TB Partnership interactive country dashboards site that presents country-based TB essential information in a manner that is simple and user friendly in easy-to-use graphs – including TB burden, TB care and service delivery, finances and selected determinants/comorbidity.

No new data is collected, rather that data is derived from the Global Fund, Institute of Health Metrics and Evaluation, the Stop TB Partnership, WHO and the World Bank – as indicated in the dashboards.*

Petition signed by more than 35,000 people from 120 countries presented to  Dr. Tedros, head of WHO and Ministers of Health.

In Moscow, the Stop TB Partnership and MSF released the report ‘Out of Step in Eastern Europe and Central Asia’ (EECA), presenting the results of an eight-country survey of national TB policies and practices. Among the countries surveyed, 75% have adopted the policy to use rapid molecular testing instead of older, slower testing methods, yet only half of those countries are actually using the test widely.

“In TB, we fight not only with mycobacterium tuberculosis, but also with the time. When we look at policies and guidelines and if country programmes need to update them, this is not an easy task, and it will take a lot of time to make it happen. If you add the time to have it approved and start the roll out, we are speaking here of years, not months. This is why it is important to keep up with the new recommendations and be able to adjust and adapt to the country context rapidly,” said Dr Lucica Ditiu, Executive Director of the Stop TB Partnership.

At the Global Ministerial Conference, Mariam Avanesova, who was treated for MDR-TB in Armenia in 2010-2012 and represents TBpeople, the Eurasian network of people with TB experience, handed over a petition to WHO’s Director-General, Dr. Tedros Ghebreyesus. The #StepUpforTB petition is an urgent call for health ministers in key TB-affected countries to get their TB policies and practices in line with international standards, as defined by WHO, including testing and treatment of TB and its drug-resistant forms. Initiated by MSF and the Stop TB Partnership, the petition has been signed by more than 35,000 people from 120 countries united with people affected by TB.

Source: Stop TB Partnership